{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:58:11Z","timestamp":1790117891996,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.drugalcdep.2008.06.018","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T17:59:59Z","timestamp":1220810399000},"page":"327-332","source":"Crossref","is-referenced-by-count":45,"title":["Prevalence of long QTc interval in methadone maintenance patients"],"prefix":"10.1016","volume":"99","author":[{"given":"Francina","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Marti-Almor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Cladellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mag\u00ed","family":"Farr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Torrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2008.06.018_bib1","first-page":"353","article-title":"An analysis of the time-relations of electrocardiograms","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1360-0443.2005.01089.x","article-title":"Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain","volume":"100","author":"Brugal","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jinf.2006.11.001","article-title":"Role of antiretroviral treatment in prolonging QTc interval in HIV-positive patients","volume":"54","author":"Chinello","year":"2007","journal-title":"J. Infect."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjmed.2007.10.009","article-title":"A community-based evaluation of sudden death associated with therapeutic levels of methadone","volume":"121","author":"Chugh","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jpainsymman.2004.06.012","article-title":"Measurement of QTc in patients receiving chronic methadone therapy","volume":"29","author":"Cruciani","year":"2005","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.clpt.6100120","article-title":"Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers","volume":"81","author":"Eap","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s002280050128","article-title":"Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: interindividual variability of the (R)-\/(S)-ratios and evidence of adaptative changes in methadone pharmacokinetics","volume":"50","author":"Eap","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib9","unstructured":"European Agency for the Evaluation of Medical Products. Committee for Propietary Medical Products, 2005. The Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. CHMP\/ICH\/2\/04. http:\/\/www.emea.europa.eu\/pdfs\/human\/ich\/000204en.pdf [Accessed on 15 October 2007]."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9149(00)01170-X","article-title":"Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects","volume":"86","author":"Festa","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib11","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2125.2004.02079.x","article-title":"Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients","volume":"57","author":"Foster","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpainsymman.2006.02.010","article-title":"Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: a prospective 9-month follow-up study","volume":"32","author":"Fredheim","year":"2006","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ahj.2007.01.040","article-title":"Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes","volume":"153","author":"Gupta","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib14","unstructured":"Hothorn, T., Hornik, K., 2006. ExactRankTests: Exact Distributions for Rank and Permutation Tests. R package version 0.8-16."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1360-0443.2006.01512.x","article-title":"Methadone-associated Torsades de Pointes (polymorphic ventricular tachycardia) in opioid-dependent patients","volume":"101","author":"Justo","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib16","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/elps.200305418","article-title":"Chiral separation of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP) by capillary electrophoresis using cyclodextrin derivatives","volume":"24","author":"Kelly","year":"2003","journal-title":"Electrophoresis"},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0304-3959(03)00205-7","article-title":"QTc interval prolongation associated with intravenous methadone","volume":"105","author":"Kornick","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-137-6-200209170-00010","article-title":"Torsade de pointes associated with very-high-dose methadone","volume":"137","author":"Krantz","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib19","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1592\/phco.2005.25.11.1523","article-title":"Effects of methadone on QT-interval dispersion","volume":"25","author":"Krantz","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib20","unstructured":"Leavitt, S.B., 2005. Methadone-Drug* Interactions (*Medications, illicit drugs, & other substances). Addiction Treatment Forum. Third ed. Available at: http:\/\/www.atforum.com\/SiteRoot\/pages\/addiction_resources\/Drug_Interactions.pdf [Accessed 15 October 2007]."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000081416","article-title":"QTc interval prolongation in patients on long-term methadone maintenance therapy","volume":"11","author":"Maremmani","year":"2005","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.amjcard.2004.11.055","article-title":"Impact of methadone treatment on cardiac repolarization and conduction in opioid users","volume":"95","author":"Martell","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7326\/0003-4819-139-2-200307150-00021","article-title":"The impact of methadone induction on cardiac conduction in opiate users","volume":"139","author":"Martell","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2125.2004.02221.x","article-title":"Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure","volume":"58","author":"Mitchell","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jelectrocard.2005.09.001","article-title":"Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients","volume":"39","author":"Nordin","year":"2006","journal-title":"J. Electrocardiol."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pds.1112","article-title":"QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system","volume":"14","author":"Pearson","year":"2005","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1360-0443.2006.01668.x","article-title":"Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients\u2014a cross-sectional study","volume":"102","author":"Peles","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.jcp.0000132347.81455.57","article-title":"QT interval prolongation in patients on methadone with concomitant drugs","volume":"24","author":"Piguet","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMcp0706513","article-title":"Long-QT syndrome","volume":"358","author":"Roden","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib30","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.CIR.88.2.782","article-title":"Diagnostic criteria for the long QT syndrome: an update","volume":"88","author":"Schwartz","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/15563650701275322","article-title":"QT prolongation and delayed atrioventricular conduction caused by acute ingestion of trazodone","volume":"46","author":"Service","year":"2008","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/01.jcp.0000246218.28186.5d","article-title":"Methadone and the QT interval. Relations to the serum concentrations of methadone and its enantiomers (R)-methadone and (S)-methadone","volume":"6","author":"Skjervold","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2008.06.018_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0376-8716(98)00096-9","article-title":"Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program","volume":"52","author":"Torrens","year":"1998","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871608002524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871608002524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T21:26:01Z","timestamp":1545773161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871608002524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":33,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0376871608002524"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2008.06.018","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}